Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maribel Teixeira

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
International Journal of Behavioral Medicine|December 8, 2016
Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology SymptomsVera Almeida, Sofia Taveira, Maribel Teixeira, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthoneMaribel Teixeira, Maria J Alonso, Madalena M M Pinto, et al.
Journal of Drug Targeting|April 13, 2005
Improvement of the inhibitory effect of xanthones on NO production by encapsulation in PLGA nanocapsulesMaribel Teixeira, Fátima Cerqueira, Carlos Maurício Barbosa, et al.
Journal of Chromatographic Science|July 24, 2008
Development and validation of an HPLC method for the quantitation of 1,3-dihydroxy-2-methylxanthone in biodegradable nanoparticlesMaribel Teixeira, Carlos M M Afonso, Madalena M M Pinto, et al.
Journal of Chromatographic Science|August 12, 2003
A validated HPLC method for the assay of xanthone and 3-methoxyxanthone in PLGA nanocapsulesMaribel Teixeira, Carlos M M Afonso, Madalena M M M Pinto, et al.
Journal of Dermatological Science|February 27, 2016
Methodologies for medication adherence evaluation: Focus on psoriasis topical treatmentAna Teixeira, Maribel Teixeira, Vera Almeida, et al.
Pharmaceutical Development and Technology|July 5, 2019
Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell lineMaribel Teixeira, Madalena Pedro, Maria São José Nascimento, et al.
American Journal of Clinical Dermatology|March 22, 2017
Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP)Ana Teixeira, Carolina Oliveira, Maribel Teixeira, et al.
Pharmaceutics|October 23, 2021
Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in PsoriasisAna Teixeira, Maribel Teixeira, Vera Almeida, et al.
International Journal of Pharmaceutics|July 17, 2013
Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interactionAna M Paiva, Rita A Pinto, Maribel Teixeira, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
International Journal of Behavioral Medicine|December 8, 2016
Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology SymptomsVera Almeida, Sofia Taveira, Maribel Teixeira, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 12, 2005
Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthoneMaribel Teixeira, Maria J Alonso, Madalena M M Pinto, et al.
Journal of Drug Targeting|April 13, 2005
Improvement of the inhibitory effect of xanthones on NO production by encapsulation in PLGA nanocapsulesMaribel Teixeira, Fátima Cerqueira, Carlos Maurício Barbosa, et al.
Journal of Chromatographic Science|July 24, 2008
Development and validation of an HPLC method for the quantitation of 1,3-dihydroxy-2-methylxanthone in biodegradable nanoparticlesMaribel Teixeira, Carlos M M Afonso, Madalena M M Pinto, et al.
Journal of Chromatographic Science|August 12, 2003
A validated HPLC method for the assay of xanthone and 3-methoxyxanthone in PLGA nanocapsulesMaribel Teixeira, Carlos M M Afonso, Madalena M M M Pinto, et al.
Journal of Dermatological Science|February 27, 2016
Methodologies for medication adherence evaluation: Focus on psoriasis topical treatmentAna Teixeira, Maribel Teixeira, Vera Almeida, et al.
Pharmaceutical Development and Technology|July 5, 2019
Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell lineMaribel Teixeira, Madalena Pedro, Maria São José Nascimento, et al.
American Journal of Clinical Dermatology|March 22, 2017
Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP)Ana Teixeira, Carolina Oliveira, Maribel Teixeira, et al.
Pharmaceutics|October 23, 2021
Does the Vehicle Matter? Real-World Evidence on Adherence to Topical Treatment in PsoriasisAna Teixeira, Maribel Teixeira, Vera Almeida, et al.
International Journal of Pharmaceutics|July 17, 2013
Development of noncytotoxic PLGA nanoparticles to improve the effect of a new inhibitor of p53-MDM2 interactionAna M Paiva, Rita A Pinto, Maribel Teixeira, et al.
Pageof 2